Targeted cancer therapy using radiolabeled monoclonal antibodies.
about
Pilot study of a (213)bismuth-labeled anti-CD45 mAb as a novel nonmyeloablative conditioning for DLA-haploidentical littermate hematopoietic transplantation.The tumour microenvironment and implications for cancer immunotherapy.Radionuclide carriers for targeting of cancer.A semiempirical model of tumor pretargeting.The role of nuclear medicine in modern therapy of cancer.Monte Carlo Calculation of Radioimmunotherapy with (90)Y-, (177)Lu-, (131)I-, (124)I-, and (188)Re-Nanoobjects: Choice of the Best Radionuclide for Solid Tumour Treatment by Using TCP and NTCP Concepts.
P2860
Targeted cancer therapy using radiolabeled monoclonal antibodies.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Targeted cancer therapy using radiolabeled monoclonal antibodies.
@ast
Targeted cancer therapy using radiolabeled monoclonal antibodies.
@en
type
label
Targeted cancer therapy using radiolabeled monoclonal antibodies.
@ast
Targeted cancer therapy using radiolabeled monoclonal antibodies.
@en
prefLabel
Targeted cancer therapy using radiolabeled monoclonal antibodies.
@ast
Targeted cancer therapy using radiolabeled monoclonal antibodies.
@en
P2860
P1476
Targeted cancer therapy using radiolabeled monoclonal antibodies.
@en
P2093
Wolfgang A Bethge
P2860
P304
P356
10.1177/153303460500400407
P577
2005-08-01T00:00:00Z